- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05858554
The Safety of Direct Laparoscopic Introduction: Retrospective Observational Study at the University Hospital of Strasbourg (Coelios)
Veress techniques and open laparoscopy are the techniques most used by gynecological surgeons to date. Advantages of the direct introduction unknown because technique still little used.
The research hypothesis is that very few major complications are expected showing the safety of direct introduction.
A look back at the practice of direct introduction into laparoscopy from 2012 to 2022 at the CMCO (Medical-Surgical and Obstetrical Center of Strasbourg)
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Victor Gabriele, MD
- Phone Number: 33 3 69 55 34 04
- Email: Victor.gabriele@chru-strasbourg.fr
Study Contact Backup
- Name: Juliana BALDASSARRE, MD
- Phone Number: 33 3 69 55 34 04
- Email: Juliana.baldassarre@chru-strasbourg.fr
Study Locations
-
-
-
Strasbourg, France, 67091
- Recruiting
- Service de Gynécologie Obstétrique - CHU de Strasbourg - France
-
Contact:
- Victor Gabriele, MD
- Phone Number: 33 3 69 55 34 04
- Email: Victor.gabriele@chru-strasbourg.fr
-
Principal Investigator:
- Victor Gabriele, MD
-
Principal Investigator:
- Juliana BALDASSARRE, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion criteria:
- Adult woman who had a scheduled or emergency laparoscopy at the CMCO between 01/01/2010 and 12/31/2022.
- Subject, having not expressed their opposition to the reuse of data of their data for the purposes of scientific research.
Exclusion criteria:
- Subject having expressed its opposition to the reuse of its data for scientific res
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Study of intraoperative complications of direct introduction in open laparoscopy
Time Frame: Files analysed retrospectively from from January 01, 2010 to December 31, 2022 will be examined
|
Files analysed retrospectively from from January 01, 2010 to December 31, 2022 will be examined
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 8952
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Laparoscopy
-
TakedaCompleted
-
Kangbuk Samsung HospitalUnknown
-
Kangbuk Samsung HospitalCompletedLaparoscopyKorea, Republic of
-
M.D. Anderson Cancer CenterTerminatedLaparoscopyUnited States
-
Marko KraljevicUniversity Hospital, Basel, SwitzerlandRecruiting
-
Kangbuk Samsung HospitalCompletedLaparoscopyKorea, Republic of
-
McGill University Health Centre/Research Institute...Unknown
-
Kangbuk Samsung HospitalUnknown
-
Medical University of ViennaCompleted
-
University Hospital, GrenobleCompleted